Nightingale Health Plc has received a CE marking for its at-home blood collection kit that it uses in its at-home solution. The at-home blood collection kit is CE marked under the category of in vitro diagnostic medical devices, and the CE marking covers the packaging, the equipment used for the blood collection and instructions for use. Nightingale has previously distributed the at-home blood collection kit in its at-home pilot under the CE marking registered by the device manufacturer, but now the CE marking registered by Nightingale enables Nightingale to operate more independently and rapidly when scaling its at-home solutions to different international markets. Registering the CE marking for the at-home blood collection kit allows Nightingale to make changes to the product according to a flexible process, which makes it possible to adjust to the needs of different markets and business partners.